Evotec - Research never stops

B1 Antagonists

Bradykinin B1 receptors represent an attractive drug target in pain and inflammation due to its upregulation of expression from near zero levels following tissue injury/inflammation. Evotec has identified highly potent B1 antagonists that show robust oral activity in vivo.